A drug created by a Texas A&M University professor could be the most effective treatment yet for patients with COVID-19, including more aggressive variants of the virus such as Delta and others.
The drug compound, called MPI8, has stopped the replication of the virus in laboratory tests. It was created by a Texas A&M research team led by biological chemist Wenshe Ray Liu, a 2018 Texas A&M Presidential Impact Fellow and holder of the Gradipore Chair in the Department of Chemistry.
The potential effectiveness of MPI8 led Sorrento Therapeutics of San Diego, Calif., to seek exclusive intellectual property rights to the ingredient. An agreement between [...]
